Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha.
- 1 September 1990
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 87 (17) , 6758-6761
- https://doi.org/10.1073/pnas.87.17.6758
Abstract
Circulating peripheral blood polymorphonuclear neutrophils (PMNs) have long been considered terminally differentiated cells that do not synthesize or secrete protein. However, work of others and ourselves has shown that PMNs can secrete the cytokine interleukin 1. In the present study we investigated whether circulating PMNs are capable of synthesizing and secreting another cytokine, tumor necrosis factor alpha (TNF-alpha). Highly purified (greater than 99% granulocytes) PMNs were isolated from normal human volunteer blood and cultured with or without bacterial lipopolysaccharide (LPS) for up to 24 hr. Cell culture supernatants were collected and tested for TNF-alpha, and total RNA was isolated from cells at various times after stimulation and assessed for TNF-alpha mRNA by Northern blot techniques. The results showed that message for TNF-alpha was produced after 60 min of in vitro stimulation with LPS and was maximal at about 4 hr. TNF-alpha was secreted into the supernatant of unstimulated PMNs from two different donors during 24 hr of culture (35-50 pg/ml), but significantly more (160-190 pg/ml) was secreted by PMNs when stimulated with LPS. PMNs from six other normal volunteers showed significant LPS-stimulated secretion of TNF at 60-180 min of culture. The secreted product also had biological activity against the TNF-sensitive L-M cell line, confirming that PMNs can make and secrete immunologically and biologically active TNF. Since it is also possible for monocytes to synthesize and secrete TNF, the amount of TNF secreted by a monocyte population equal to 20% of the PMNs cultured was measured. The results showed that monocytes at a concentration 20 times that potentially contaminating the PMN populations cultured could not produce as much TNF (unstimulated, 26-65 pg/ml; stimulated, 32-87 pg/ml). The PMN must now be considered a cell capable of altering the acute inflammatory response and modulating the immune response through the synthesis and release of cytokines.This publication has 18 references indexed in Scilit:
- Assays for tumour necrosis factor and related cytokinesJournal of Immunological Methods, 1989
- Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.Proceedings of the National Academy of Sciences, 1988
- Selective synthesis of mRNA and proteins by human peripheral blood neutrophils.The Journal of Immunology, 1988
- Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor.The Journal of Immunology, 1987
- Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption.The Journal of Immunology, 1987
- Interleukin 1 production by human polymorphonuclear neutrophils.The Journal of Immunology, 1986
- Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- Expression of the c-fms proto-oncogene during human monocytic differentiationNature, 1985
- Cytochemical Identification of Monocytes and GranulocytesAmerican Journal of Clinical Pathology, 1971